Clinical trial
Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or…
NCT00048529 · Tularik, Industry · Suspended
Key facts
| NCT number | NCT00048529 |
|---|---|
| Title | Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus |
| Lead sponsor | Tularik, Industry |
| Status | Suspended |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer, Esophageal Neoplasms |
| Intervention type | Drug |
| Interventions | T900607-sodium intravenous |
| Enrollment | 70 |
| Start date | Sep 1, 2002 |
| First posted | Nov 4, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: